Los Gatos, California-based Advanced NanoTherapies received the investment from a medical device company. It also announced the successful treatment of the first cohort of study participants in its drug-coated balloon trial. The first-in-human trial evaluates initial short-term safety data for the next-generation SirPlux Duo drug-coated balloon. It looks at the balloon in treating de novo coronary artery disease (CAD).
Get the full story at our sister site, Drug Delivery Business News.
